87 results on '"LaRocque, Regina C."'
Search Results
2. Case 3-2019: A 70-Year-Old Woman with Fever, Headache, and Progressive Encephalopathy.
- Author
-
Zachary, Kimon C., LaRocque, Regina C., Gonzalez, R. Gilberto, and Branda, John A.
- Subjects
- *
EPIDEMIC encephalitis complications , *BRAIN diseases , *BRAIN , *DIFFERENTIAL diagnosis , *EPIDEMIC encephalitis , *FEVER , *FLAVIVIRUSES , *HEADACHE , *IMMUNOGLOBULINS , *MAGNETIC resonance imaging , *MENINGOENCEPHALITIS , *DISEASE complications ,MIGRAINE complications - Abstract
The article discusses the case of a patient diagnosed with Powasan virus encephalitis. Topics discussed include the patient's clinical presentation of fever, headache and progressive encephalopathy, differential diagnosis which include bacterial, fungal and arthropod-borne virus infections, and the results of laboratory tests, computed tomography and magnetic resonance imaging (MRI) of the head. Also discussed are the characteristics of Powassan flavivirus and the treatment of the patient.
- Published
- 2019
- Full Text
- View/download PDF
3. In the Clinic®. Travel Medicine.
- Author
-
Leung, Daniel T, LaRocque, Regina C, and Ryan, Edward T
- Subjects
- *
PREVENTION of bites & stings , *DECOMPRESSION sickness , *MOUNTAIN sickness , *PREVENTION of sexually transmitted diseases , *TRAFFIC safety , *PREVENTION of injury , *ZOONOSES , *AIRPLANES , *ANIMALS , *INSECTS , *PRIMARY health care , *SHIPS , *TRAVEL hygiene , *FOOD safety , *PREVENTION - Published
- 2018
- Full Text
- View/download PDF
4. Climate Change - A Health Emergency.
- Author
-
Solomon, Caren G. and LaRocque, Regina C.
- Subjects
- *
HEALTH behavior , *PHYSICIANS , *PUBLIC health , *PUBLIC opinion , *OCCUPATIONAL roles , *PHENOMENOLOGICAL biology - Abstract
The authors comment on research published within the issue, that examined the detrimental environmental effects of burning fossil fuel. Topics discussed include disruption of climate system such as flooding, droughts and wildfires, the greenhouse gas emissions of the health care system in the U.S., and the responsibility of physicians to safeguard health and alleviate suffering.
- Published
- 2019
- Full Text
- View/download PDF
5. Universal Masking in Health Care Settings.
- Author
-
Brown, Tyler S., Mohareb, Amir M., and LaRocque, Regina C.
- Subjects
- *
UNIVERSAL healthcare , *POOR communities , *SOCIAL marginality , *VACCINATION coverage , *INFECTION control - Abstract
This article discusses the ongoing debate surrounding universal masking in healthcare settings. While some argue for the elimination of universal masking, the authors express concern about the potential negative consequences, particularly for socially disadvantaged communities. These communities have already experienced disparities throughout the pandemic, including higher infection rates, lower vaccination coverage, and limited access to testing and treatments. The authors disagree with the viewpoint that eliminates universal masking, as they believe it will further concentrate the risk and burden of COVID-19 among the most disadvantaged, potentially damaging public trust in the healthcare system. They emphasize the importance of including diverse voices in health policy decisions and involving both infection control professionals and community members in discussions about mask requirements. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
6. Pre-Travel Health Preparation of Pediatric International Travelers: Analysis From the Global TravEpiNet Consortium.
- Author
-
Hagmann, Stefan, LaRocque, Regina C., Rao, Sowmya R., Jentes, Emily S., Sotir, Mark J., Brunette, Gary, and Ryan, Edward T.
- Subjects
- *
TRAVEL with children , *TRAVEL hygiene , *INTERNATIONAL travel , *COMMUNICABLE diseases in children , *PEDIATRIC research - Abstract
Background Children frequently travel internationally. Health-related data on such children are limited. We sought to investigate the demographics, health characteristics, and preventive interventions of outbound US international pediatric travelers. Methods We analyzed data from 32 099 travelers presenting for pre-travel healthcare at the Global TravEpiNet (GTEN), a national consortium of 19 travel clinics, from January 1, 2009 to June 6, 2012. Results A total of 3332 (10%) of all GTEN travelers were children (<18 years of age). These children traveled mostly for leisure (36%) or to visit friends or relatives (VFR) (36%). Most popular destination regions were Africa (41%), Southeast Asia (16%), Central America (16%), and the Caribbean (16%). Compared with children traveling for leisure, VFR children were more likely to present <14 days before departure for pre-travel consultation (44% vs 28%), intended to travel for 28 days or longer (70% vs 22%), and to travel to Africa (62% vs 32%). Nearly half of the pediatric travelers (46%) received at least 1 routine vaccine, and most (83%) received at least 1 travel-related vaccine. Parents or guardians of one third of the children (30%) refused at least 1 recommended travel-related vaccine. Most pediatric travelers visiting a malaria-endemic country (72%) received a prescription for malaria chemoprophylaxis. Conclusions Ten percent of travelers seeking pre-travel healthcare at GTEN sites are children. VFR-travel, pre-travel consultation close to time of departure, and refusal of recommended vaccines may place children at risk for travel-associated illness. Strategies to engage pediatric travelers in timely, pre-travel care and improve acceptance of pre-travel healthcare interventions are needed. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
7. Hiding in Plain View: Cholera in Bangladesh.
- Author
-
Harris, Jason B and Larocque, Regina C
- Subjects
- *
PREVENTION of cholera , *CHOLERA , *HOSPITALS , *PUBLIC health , *PUBLIC health surveillance - Abstract
The article discusses that the the World Health Organization (WHO) Global Task Force on Cholera Control announced an initiative titled Ending Cholera; and the objective was a 90% reduction in cholera deaths and the elimination of cholera in 20 countries, including Bangladesh, by 2030. It mentions that the introduction of cholera in Haiti in 2010 spurred new partnerships, investments, and calls to action, prompting the establishment of a global stockpile.
- Published
- 2020
- Full Text
- View/download PDF
8. Cholera.
- Author
-
Harris, Jason B., LaRocque, Regina C., Qadri, Firdausi, Ryan, Edward Τ., and Calderwood, Stephen B.
- Subjects
- *
CHOLERA , *PATHOLOGICAL physiology , *INFECTION , *VIBRIO cholerae , *GASTRIC acid - Abstract
The article offers information on the history, pathophysiology and pathogenesis of cholera disease. It states that cholera is an acute, secretory diarrhoea caused by infection with vibrio cholerae of the 01 or 0139 serogroup and in 1817 cholera spread beyond the Indian subcontinent. It states that after ingestion of V cholerae, most of the bacteria are killed by gastric acid.
- Published
- 2012
- Full Text
- View/download PDF
9. Global TravEpiNet: A National Consortium of Clinics Providing Care to International Travelers-Analysis of Demographic Characteristics, Travel Destinations, and Pretravel Healthcare of High-Risk US International Travelers, 2009-2011.
- Author
-
LaRocque, Regina C., Rao, Sowmya R., Lee, Jennifer, Ansdell, Vernon, Yates, Johnnie A., Schwartz, Brian S., Knouse, Mark, Cahill, John, Hagmann, Stefan, Vinetz, Joseph, Connor, Bradley A., Goad, Jeffery A., Oladele, Alawode, Alvarez, Salvador, Stauffer, William, Walker, Patricia, Kozarsky, Phyllis, Paredes, Carlos Franco, Dismukes, Roberta, and Rosen, Jessica
- Subjects
- *
MEDICAL care , *DISEASE risk factors , *COMMUNICABLE diseases , *YELLOW fever vaccines , *EPIDEMIOLOGY - Abstract
Background. International travel poses a risk of destination-specific illness and may contribute to the global spread of infectious diseases. Despite this, little is known about the health characteristics and pretravel healthcare of US international travelers, particularly those at higher risk of travel-associated illness. Methods. We formed a national consortium (Global TravEpiNet) of 18 US clinics registered to administer yellow fever vaccination. We collected data regarding demographic and health characteristics, destinations, purpose of travel, and pretravel healthcare from 13 235 international travelers who sought pretravel consultation at these sites from January 2009 through January 2011. Results. The destinations and itineraries of Global TravEpiNet travelers differed from those of the overall population of US international travelers. The majority of Global TravEpiNet travelers were visiting low- or lower-middle-income countries, and Africa was the most frequently visited region. Seventy-five percent of travelerswere visitingmalaria-endemic countries, and 38% were visiting countries endemic for yellow fever. Fifty-nine percent of travelers reported ≤1 medical condition. Atovaquone/proguanil was the most commonly prescribed antimalarial drug, and most travelers received an antibiotic for self-treatment of travelers' diarrhea. HepatitisA and typhoid were themost frequently administered vaccines. Conclusions. Data from Global TravEpiNet provide insight into the characteristics and pretravel healthcare of US international travelers who are at increased risk of travel-associated illness due to itinerary, purpose of travel, or existing medical conditions. Improved understanding of this epidemiologically significant population may help target risk-reduction strategies and interventions to limit the spread of infections related to global travel [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
10. Cholera's western front.
- Author
-
Harris, Jason B., LaRocque, Regina C., Charles, Richelle C., Mazumder, Ramendra N., Khan, Azharul I., and Bardhan, Pradip K.
- Subjects
- *
CHOLERA , *EPIDEMICS , *PUBLIC health , *DEATH rate - Abstract
The article comments on the impact of the cholera epidemic on the public health landscape of the western hemisphere. It notes that the public health infrastructure in several Latin American and Caribbean countries has been strengthened following the 1991 outbreak. Particular focus is given to the cholera outbreak in Haiti in 2010, along with the case fatality rates of in the past 10 years. It cites the biological and organisational challenges involved in achieving low rates of case fatality during an outbreak.
- Published
- 2010
- Full Text
- View/download PDF
11. Pre-travel Health Advice-Seeking Behavior Among US International Travelers Departing From Boston Logan International Airport LaRocque et al.
- Author
-
LaRocque, Regina C., Rao, Sowmya R., Tsibris, Athe, Lawton, Thomas, Barry, M. Anita, Marano, Nina, Brunette, Gary, Yanni, Emad, and Ryan, Edward T.
- Subjects
- *
TRAVEL hygiene , *INTERNATIONAL travel , *SURVEYS , *MEDICAL informatics - Abstract
Globally mobile populations are at higher risk of acquiring geographically restricted infections and may play a role in the international spread of infectious diseases. Despite this, data about sources of health information used by international travelers are limited. We surveyed 1,254 travelers embarking from Boston Logan International Airport regarding sources of health information. We focused our analysis on travelers to low or low-middle income (LLMI) countries, as defined by the World Bank 2009 World Development Report. A total of 476 survey respondents were traveling to LLMI countries. Compared with travelers to upper-middle or high income (UMHI) countries, travelers to LLMI countries were younger, more likely to be foreign-born, and more frequently reported visiting family as the purpose of their trip. Prior to their trips, 46% of these travelers did not pursue health information of any type. In a multivariate analysis, being foreign-born, traveling alone, traveling for less than 14 days, and traveling for vacation each predicted a higher odds of not pursuing health information among travelers to LLMI countries. The most commonly cited reason for not pursuing health information was a lack of concern about health problems related to the trip. Among travelers to LLMI countries who did pursue health information, the internet was the most common source, followed by primary care practitioners. Less than a third of travelers to LLMI countries who sought health information visited a travel medicine specialist. In our study, 46% of travelers to LLMI countries did not seek health advice prior to their trip, largely due to a lack of concern about health issues related to travel. Among travelers who sought medical advice, the internet and primary care providers were the most common sources of information. These results suggest the need for health outreach and education programs targeted at travelers and primary care practitioners. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
12. Leptospirosis during dengue outbreak, Bangladesh.
- Author
-
LaRocque, Regina C., Breiman, Robert F., Ari, Mary D., Morey, Roger E., Janan, Firdous Ara, Hayes, John Mosely, Hossain, M. Anowar, Brooks, W. Abdullah, and Levett, Paul N.
- Subjects
- *
LEPTOSPIROSIS , *DENGUE , *DISEASE outbreaks , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *TIME , *EVALUATION research , *RETROSPECTIVE studies - Abstract
We collected acute-phase serum samples from febrile patients at 2 major hospitals in Dhaka, Bangladesh, during an outbreak of dengue fever in 2001. A total of 18% of dengue-negative patients tested positive for leptospirosis. The case-fatality rate among leptospirosis patients (5%) was higher than among dengue fever patients (1.2%). [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
13. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
- Author
-
Saha, Debasish, LaRocque, Regina C., Khan, Ashraful I., Harris, Jason B., Begum, Yasmin Ara, Akramuzzaman, Syed M., Faruque, Abu S. G., Ryan, Edward T., Qadri, Firdausi, and Calderwood, Stephen B.
- Subjects
- *
CHOLERA , *SERUM , *BLOOD plasma , *VIBRIO infections , *GRAM-negative bacterial diseases , *BLOOD plasma substitutes - Abstract
The serum vibriocidal antibody is the only recognized predictor of protection from cholera, but no seroepidemiological data have been gathered since the emergence of Vibrio cholerae O139. We assessed the association between the vibriocidal antibody titer and protection from cholera in an endemic setting. Although a higher baseline vibriocidal titer correlated with protection from V. cholerae O1, infection still developed in some contacts with very high titers. No association between baseline vibriocidal titer and protection from V. cholerae O139 infection was found. Our findings suggest that the vibriocidal antibody is an incomplete predictor of protection from V. cholerae infection. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
14. The Utility of Sputum Induction for Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus.
- Author
-
LaRocque, Regina C., Katz, Joel T., Perruzzi, Priscilla, and Baden, Lindsey R.
- Subjects
- *
SPUTUM microbiology , *PNEUMOCYSTIS pneumonia , *LUNG diseases , *IMMUNODEFICIENCY , *HIV-positive persons , *DIAGNOSTIC microbiology , *MEDICAL research - Abstract
Focuses on sputum induction (SI) vis-a-vis Pneumocystis pneumonia in immunocompromised patients without HIV in the U.S. Application of SI among immunocompromised patients; Importance of the application of SI for diagnosis of Pneumocystis pneumonia; Comparison of the clinical study on the outcome of SI between immunocompromised patients with HIV and those without HIV.
- Published
- 2003
- Full Text
- View/download PDF
15. Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection.
- Author
-
Roach, David J, Sridhar, Sushmita, Oliver, Elizabeth, Rao, Sowmya R, Slater, Damien M, Hwang, Wontae, Vater, Kian Hutt, Dinesh, Anupama, Qadri, Firdausi, Chisti, Mohammod J, Pierce, Virginia M, Turbett, Sarah E, Bhattacharyya, Roby P, Worby, Colin J, Earl, Ashlee M, LaRocque, Regina C, and Harris, Jason B
- Subjects
- *
BACTEREMIA , *KLEBSIELLA , *SEQUENCE analysis , *CONFIDENCE intervals , *MANN Whitney U Test , *ACQUISITION of data , *KLEBSIELLA infections , *RISK assessment , *HOSPITAL mortality , *T-test (Statistics) , *GENOMES , *SYMPTOMS , *RESEARCH funding , *DESCRIPTIVE statistics , *CHI-squared test , *MEDICAL records , *DRUG resistance in microorganisms , *DATA analysis software , *ODDS ratio , *LOGISTIC regression analysis , *MICROBIAL virulence - Abstract
Background The clinical and microbial factors associated with Klebsiella pneumoniae bloodstream infections (BSIs) are not well characterized. Prior studies have focused on highly resistant or hypervirulent isolates, limiting our understanding of K. pneumoniae strains that commonly cause BSI. We performed a record review and whole-genome sequencing to investigate the clinical characteristics, bacterial diversity, determinants of antimicrobial resistance, and risk factors for in-hospital death in a cohort of patients with K. pneumoniae BSI. Methods We identified 562 patients at Massachusetts General Hospital with K. pneumoniae BSIs between 2016 and 2022. We collected data on comorbid conditions, infection source, clinical outcomes, and antibiotic resistance and performed whole-genome sequencing on 108 sequential BSI isolates from 2021 to 2022. Results Intra-abdominal infection was the most common source of infection accounting for 34% of all BSIs. A respiratory tract source accounted for 6% of BSIs but was associated with a higher in-hospital mortality rate (adjusted odds ratio, 5.4 [95% confidence interval, 2.2–12.8]; P <.001 for comparison with other sources). Resistance to the first antibiotic prescribed was also associated with a higher risk of death (adjusted odds ratio, 5.2 [95% confidence interval, 2.2–12.4]; P <.001). BSI isolates were genetically diverse, and no clusters of epidemiologically and genetically linked cases were observed. Virulence factors associated with invasiveness were observed at a low prevalence, although an unexpected association between O-antigen type and the source of infection was found. Conclusions These observations demonstrate the versatility of K. pneumoniae as an opportunistic pathogen and highlight the need for new approaches for surveillance and the rapid identification of patients with invasive antimicrobial-resistant K. pneumoniae infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Development of a prediction model for the acquisition of extended spectrum beta-lactam-resistant organisms in U.S. international travellers.
- Author
-
Brown, David Garrett, Worby, Colin J, Pender, Melissa A, Brintz, Ben J, Ryan, Edward T, Sridhar, Sushmita, Oliver, Elizabeth, Harris, Jason B, Turbett, Sarah E, Rao, Sowmya R, Earl, Ashlee M, LaRocque, Regina C, and Leung, Daniel T
- Subjects
- *
RECEIVER operating characteristic curves , *CLINICAL prediction rules , *PREDICTION models , *BETA lactam antibiotics , *FEATURE selection - Abstract
Background Extended spectrum beta-lactamase producing Enterobacterales (ESBL-PE) present a risk to public health by limiting the efficacy of multiple classes of beta-lactam antibiotics against infection. International travellers may acquire these organisms and identifying individuals at high risk of acquisition could help inform clinical treatment or prevention strategies. Methods We used data collected from a cohort of 528 international travellers enrolled in a multicentre US-based study to derive a clinical prediction rule (CPR) to identify travellers who developed ESBL-PE colonization, defined as those with new ESBL positivity in stool upon return to the United States. To select candidate features, we used data collected from pre-travel and post-travel questionnaires, alongside destination-specific data from external sources. We utilized LASSO regression for feature selection, followed by random forest or logistic regression modelling, to derive a CPR for ESBL acquisition. Results A CPR using machine learning and logistic regression on 10 features has an internally cross-validated area under the receiver operating characteristic curve (cvAUC) of 0.70 (95% confidence interval 0.69–0.71). We also demonstrate that a four-feature model performs similarly to the 10-feature model, with a cvAUC of 0.68 (95% confidence interval 0.67–0.69). This model uses traveller's diarrhoea, and antibiotics as treatment, destination country waste management rankings and destination regional probabilities as predictors. Conclusions We demonstrate that by integrating traveller characteristics with destination-specific data, we could derive a CPR to identify those at highest risk of acquiring ESBL-PE during international travel. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Medical Considerations before International Travel.
- Author
-
LaRocque, Regina C and Ryan, Edward T
- Subjects
- *
COMMUNICABLE diseases , *TRAVEL - Published
- 2016
- Full Text
- View/download PDF
18. Knowledge, attitudes and practices regarding the use of mobile travel health apps.
- Author
-
Machoko, Munashe M P, Dong, Yinan, Grozdani, Andonaq, Hong, Hung, Oliver, Elizabeth, Hyle, Emily P, Ryan, Edward T, Colubri, Andrés, and LaRocque, Regina C
- Subjects
- *
NAVIGATION & travel mobile apps , *SCIENTIFIC literature , *TRAVEL hygiene , *MOBILE hospitals , *MEDICAL care costs , *HEALTH facilities - Abstract
This article discusses the knowledge, attitudes, and practices of US international travelers regarding the use of mobile travel health apps. The study collected data from 261 participants through an electronic survey, which assessed their smartphone usage habits, internet accessibility while traveling, concerns about personal health, and preferences for features in a travel health app. The majority of participants reported always carrying a smartphone during international travel and expressed interest in receiving health information through a travel health app. Preferred features for the app included real-time alerts about local outbreaks, information about nearby medical facilities, and COVID-19 travel-related restrictions. However, some participants had concerns about data security and privacy. The study provides insights into travelers' perspectives on mobile health apps and supports further development in this area. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
19. Influenza: seasonality and travel-related considerations.
- Author
-
Kakoullis, Loukas, Steffen, Robert, Osterhaus, Albert, Goeijenbier, Marco, Rao, Sowmya R, Koiso, Satoshi, Hyle, Emily P, Ryan, Edward T, LaRocque, Regina C, and Chen, Lin H
- Subjects
- *
MEDICAL personnel , *INFLUENZA , *FLU vaccine efficacy , *SEASONAL influenza , *SEASONAL variations of diseases , *VACCINATION - Abstract
Rationale for review This review aims to summarize the transmission patterns of influenza, its seasonality in different parts of the globe, air travel- and cruise ship-related influenza infections and interventions to reduce transmission. Key findings The seasonality of influenza varies globally, with peak periods occurring mainly between October and April in the northern hemisphere (NH) and between April and October in the southern hemisphere (SH) in temperate climate zones. However, influenza seasonality is significantly more variable in the tropics. Influenza is one of the most common travel-related, vaccine-preventable diseases and can be contracted during travel, such as during a cruise or through air travel. Additionally, travellers can come into contact with people from regions with ongoing influenza transmission. Current influenza immunization schedules in the NH and SH leave individuals susceptible during their respective spring and summer months if they travel to the other hemisphere during that time. Conclusions/recommendations The differences in influenza seasonality between hemispheres have substantial implications for the effectiveness of influenza vaccination of travellers. Health care providers should be aware of influenza activity when patients report travel plans, and they should provide alerts and advise on prevention, diagnostic and treatment options. To mitigate the risk of travel-related influenza, interventions include antivirals for self-treatment (in combination with the use of rapid self-tests), extending the shelf life of influenza vaccines to enable immunization during the summer months for international travellers and allowing access to the influenza vaccine used in the opposite hemisphere as a travel-related vaccine. With the currently available vaccines, the most important preventive measure involves optimizing the seasonal influenza vaccination. It is also imperative that influenza is recognized as a travel-related illness among both travellers and health care professionals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Travel Characteristics and Pretravel Health Care Among Pregnant or Breastfeeding U.S. Women Preparing for International Travel.
- Author
-
Hagmann, Stefan H. F., Rao, Sowmya R., LaRocque, Regina C., Erskine, Stefanie, Jentes, Emily S., Walker, Allison T., Barnett, Elizabeth D., Chen, Lin H., Hamer, Davidson H., Ryan, Edward T., and Global TravEpiNet Consortium and the Boston Area Travel Medicine Network
- Subjects
- *
BREASTFEEDING , *MATERNAL health , *SOCIAL aspects of travel , *PREVENTIVE medicine , *VACCINES , *YELLOW fever vaccines - Abstract
Objective: To study characteristics and preventive interventions of adult pregnant and breastfeeding travelers seeking pretravel health care in the United States.Methods: This cross-sectional study analyzed data (2009-2014) of pregnant and breastfeeding travelers seen at U.S. travel clinics participating in Global TravEpiNet. Nonpregnant, nonbreastfeeding adult female travelers of childbearing age were used for comparison. We evaluated the prescription of malaria chemoprophylaxis and antibiotics for this population as well as the administration of three travel-related vaccines: hepatitis A, typhoid, and yellow fever. We also evaluated use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccines, because these are widely recommended in pregnancy.Results: Of 21,138 female travelers of childbearing age in Global TravEpiNet, 170 (0.8%) were pregnant and 139 (0.7%) were breastfeeding. Many traveled to destinations endemic for mosquito-borne illnesses, including malaria (pregnant: 95%; breastfeeding: 94%), dengue (pregnant: 87%; breastfeeding: 81%), or yellow fever (pregnant: 35%; breastfeeding: 50%). Compared with nonpregnant, nonbreastfeeding adult female travelers, eligible pregnant travelers were less likely to be vaccinated against hepatitis A (28% compared with 51%, P<.001) and typhoid (35% compared with 74%, P<.001). More than 20% of eligible pregnant travelers did not receive influenza vaccination. Yellow fever vaccine was occasionally provided to pregnant and breastfeeding travelers traveling to countries entirely endemic for yellow fever (6 [20%] of 30 pregnant travelers and 18 [46%] of 39 breastfeeding travelers). Half of pregnant travelers and two thirds of breastfeeding travelers preparing to travel to malaria-holoendemic countries received a prescription for malaria prophylaxis.Conclusion: Most pregnant and breastfeeding travelers seen for pretravel health consultations traveled to destinations with high risk for vector-borne or other travel-related diseases. Destination-specific preventive interventions were frequently underused. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
21. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
- Author
-
Turbett, Sarah E, Tomkins-Tinch, Christopher H, Anahtar, Melis N, Dugdale, Caitlin M, Hyle, Emily P, Shenoy, Erica S, Shaw, Bennett, Egbuonu, Kenechukwu, Bowman, Kathryn A, Zachary, Kimon C, Adams, Gordon C, Hooper, David C, Ryan, Edward T, LaRocque, Regina C, Bassett, Ingrid V, Triant, Virginia A, Siddle, Katherine J, Rosenberg, Eric, Sabeti, Pardis C, and Schaffner, Stephen F
- Subjects
- *
SARS-CoV-2 , *COVID-19 , *ACADEMIC medical centers , *REINFECTION , *RNA , *RETROSPECTIVE studies , *ACQUISITION of data , *RISK assessment , *GENOMES , *MEDICAL records , *DESCRIPTIVE statistics , *GENETIC techniques , *LONGITUDINAL method , *NUCLEIC acid amplification techniques - Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection is poorly understood, partly because few studies have systematically applied genomic analysis to distinguish reinfection from persistent RNA detection related to initial infection. We aimed to evaluate the characteristics of SARS-CoV-2 reinfection and persistent RNA detection using independent genomic, clinical, and laboratory assessments. Methods All individuals at a large academic medical center who underwent a SARS-CoV-2 nucleic acid amplification test (NAAT) ≥45 days after an initial positive test, with both tests between 14 March and 30 December 2020, were analyzed for potential reinfection. Inclusion criteria required having ≥2 positive NAATs collected ≥45 days apart with a cycle threshold (Ct) value <35 at repeat testing. For each included subject, likelihood of reinfection was assessed by viral genomic analysis of all available specimens with a Ct value <35, structured Ct trajectory criteria, and case-by-case review by infectious diseases physicians. Results Among 1569 individuals with repeat SARS-CoV-2 testing ≥45 days after an initial positive NAAT, 65 (4%) met cohort inclusion criteria. Viral genomic analysis characterized mutations present and was successful for 14/65 (22%) subjects. Six subjects had genomically supported reinfection, and 8 subjects had genomically supported persistent RNA detection. Compared to viral genomic analysis, clinical and laboratory assessments correctly distinguished reinfection from persistent RNA detection in 12/14 (86%) subjects but missed 2/6 (33%) genomically supported reinfections. Conclusions Despite good overall concordance with viral genomic analysis, clinical and Ct value-based assessments failed to identify 33% of genomically supported reinfections. Scaling-up genomic analysis for clinical use would improve detection of SARS-CoV-2 reinfections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Climate Change and the Epidemiology of Infectious Diseases in the United States.
- Author
-
Edelson, Paul J, Harold, Rachel, Ackelsberg, Joel, Duchin, Jeffrey S, Lawrence, Steven J, Manabe, Yukari C, Zahn, Matt, and LaRocque, Regina C
- Subjects
- *
COMMUNICABLE disease epidemiology , *COCCIDIOIDOMYCOSIS , *FOSSIL fuels , *AQUATIC microbiology , *INFECTIOUS disease transmission , *DISEASE prevalence , *VECTOR-borne diseases , *DRUG resistance in microorganisms , *CLIMATE change - Abstract
The earth is rapidly warming, driven by increasing atmospheric carbon dioxide and other gases that result primarily from fossil fuel combustion. In addition to causing arctic ice melting and extreme weather events, climatologic factors are linked strongly to the transmission of many infectious diseases. Changes in the prevalence of infectious diseases not only reflect the impacts of temperature, humidity, and other weather-related phenomena on pathogens, vectors, and animal hosts but are also part of a complex of social and environmental factors that will be affected by climate change, including land use, migration, and vector control. Vector- and waterborne diseases and coccidioidomycosis are all likely to be affected by a warming planet; there is also potential for climate-driven impacts on emerging infectious diseases and antimicrobial resistance. Additional resources for surveillance and public health activities are urgently needed, as well as systematic education of clinicians on the health impacts of climate change. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Comparison of long- and short-read metagenomic assembly for low-abundance species and resistance genes.
- Author
-
Yorki, Sosie, Shea, Terrance, Cuomo, Christina A, Walker, Bruce J, LaRocque, Regina C, Manson, Abigail L, Earl, Ashlee M, and Worby, Colin J
- Subjects
- *
METAGENOMICS , *ESCHERICHIA coli , *GENES , *SPECIES , *DRUG resistance in bacteria , *MICROBIAL communities - Abstract
Recent technological and computational advances have made metagenomic assembly a viable approach to achieving high-resolution views of complex microbial communities. In previous benchmarking, short-read (SR) metagenomic assemblers had the highest accuracy, long-read (LR) assemblers generated the most contiguous sequences and hybrid (HY) assemblers balanced length and accuracy. However, no assessments have specifically compared the performance of these assemblers on low-abundance species, which include clinically relevant organisms in the gut. We generated semi-synthetic LR and SR datasets by spiking small and increasing amounts of Escherichia coli isolate reads into fecal metagenomes and, using different assemblers, examined E. coli contigs and the presence of antibiotic resistance genes (ARGs). For ARG assembly, although SR assemblers recovered more ARGs with high accuracy, even at low coverages, LR assemblies allowed for the placement of ARGs within longer, E. coli -specific contigs, thus pinpointing their taxonomic origin. HY assemblies identified resistance genes with high accuracy and had lower contiguity than LR assemblies. Each assembler type's strengths were maintained even when our isolate was spiked in with a competing strain, which fragmented and reduced the accuracy of all assemblies. For strain characterization and determining gene context, LR assembly is optimal, while for base-accurate gene identification, SR assemblers outperform other options. HY assembly offers contiguity and base accuracy, but requires generating data on multiple platforms, and may suffer high misassembly rates when strain diversity exists. Our results highlight the trade-offs associated with each approach for recovering low-abundance taxa, and that the optimal approach is goal-dependent. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions.
- Author
-
Posen, H Joshua, Wong, Waison, Farrar, Daniel S, Campigotto, Aaron, Chan, Tiffany, Barker, Kevin R, Hagmann, Stefan H F, Ryan, Edward T, LaRocque, Regina C, Earl, Ashlee M, Worby, Colin J, Castelli, Francesco, Fumadó, Victoria Pérez, Britton, Philip N, Libman, Michael, Hamer, Davidson H, and Morris, Shaun K
- Subjects
- *
TYPHOID fever , *SALMONELLA enterica serovar Typhi , *WHOLE genome sequencing , *SALMONELLA typhi - Abstract
Background Extensively drug-resistant (XDR) typhoid fever is a threat to travelers to Pakistan. We describe a multicontinental case series of travel-acquired XDR typhoid fever to demonstrate the global spread of the problem and encourage preventive interventions as well as appropriate empiric antimicrobial use. Methods Cases were extracted from the GeoSentinel database, microbiologic laboratory records of two large hospitals in Toronto, Canada, and by invitation to TropNet sites. All isolates were confirmed XDR Salmonella enterica serovar Typhi (Salmonella typhi), with resistance to ampicillin, ceftriaxone, ciprofloxacin and trimethoprim–sulfamethoxazole. Results Seventeen cases were identified in Canada (10), USA (2), Spain (2), Italy (1), Australia (1) and Norway (1). Patients under 18 years represented 71% (12/17) of cases, and all patients travelled to Pakistan to visit friends or relatives. Only one patient is known to have been vaccinated. Predominant symptoms were fever, abdominal pain, vomiting and diarrhoea. Antimicrobial therapy was started on Day 1 of presentation in 75% (12/16) of patients, and transition to a carbapenem or azithromycin occurred a median of 2 days after blood culture was drawn. Antimicrobial susceptibilities were consistent with the XDR S. typhi phenotype, and whole genome sequencing on three isolates confirmed their belonging to the XDR variant of the H58 clade. Conclusions XDR typhoid fever is a particular risk for travelers to Pakistan, and empiric use of a carbapenem or azithromycin should be considered. Pre-travel typhoid vaccination and counseling are necessary and urgent interventions, especially for visiting friends and relatives travelers. Ongoing sentinel surveillance of XDR typhoid fever is needed to understand changing epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19.
- Author
-
Gregory, David J., Vannier, Augustin, Duey, Akiro H., Roady, Tyler J., Dzeng, Richard K., Pavlovic, Maia N., Chapin, Michael H., Mukherjee, Sonia, Wilmot, Hannah, Chronos, Nic, Charles, Richelle C., Ryan, Edward T., LaRocque, Regina C., Miller, Tyler E., Garcia-Beltran, Wilfredo F., Thierauf, Julia C., Iafrate, A. John, Mullenbrock, Steven, Stump, Mark D., and Wetzel, Randall K.
- Published
- 2022
- Full Text
- View/download PDF
26. High-risk US International Travelers Seeking Pretravel Consultation During the COVID-19 Pandemic.
- Author
-
Hyle, Emily P, Le, Mylinh H, Rao, Sowmya R, Mulroy, Nora M, Walker, Allison T, Ryan, Edward T, and LaRocque, Regina C
- Subjects
- *
COVID-19 pandemic , *COVID-19 , *JAPANESE B encephalitis , *POSTVACCINAL encephalitis , *YELLOW fever - Abstract
Background To assess the implications of coronavirus disease 2019 (COVID-19)–related travel disruptions, we compared demographics and travel-related circumstances of US travelers seeking pretravel consultation regarding international travel at US Global TravEpiNet (GTEN) sites before and after the initiation of COVID-19 travel warnings. Methods We analyzed data in the GTEN database regarding traveler demographics and travel-related circumstances with standard questionnaires in the pre-COVID-19 period (January–December 2019) and the COVID-19 period (April 2020–March 2021), excluding travelers from January to March 2020. We conducted descriptive analyses of differences in demographics, travel-related circumstances, routine and travel-related vaccinations, and medications. Results Compared with 16 903 consultations in the pre-COVID-19 period, only 1564 consultations were recorded at GTEN sites during the COVID-19 period (90% reduction), with a greater proportion of travelers visiting friends and relatives (501/1564 [32%] vs 1525/16 903 [9%]), individuals traveling for >28 days (824/1564 [53%] vs 2522/16 903 [15%]), young children (6 mo–<6 y: 168/1564 [11%] vs 500/16 903 [3%]), and individuals traveling to Africa (1084/1564 [69%] vs 8049/16 903 [48%]). A smaller percentage of vaccine-eligible travelers received vaccines at pretravel consultations during the COVID-19 period than before, except for yellow fever and Japanese encephalitis vaccinations. Conclusions Compared with the pre-COVID-19 period, a greater proportion of travelers during the COVID - 19 period were young children, were planning to visit friends and relatives, were traveling for >28 days, or were traveling to Africa, which are circumstances that contribute to high risk for travel-related infections. Fewer vaccine-eligible travelers were administered travel-related vaccines at pretravel consultations. Counseling and vaccination focused on high-risk international travelers must be prioritized during the COVID-19 pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.
- Author
-
Schroeder, Philip H., Brenner, Laura N., Kaur, Varinderpal, Cromer, Sara J., Armstrong, Katrina, LaRocque, Regina C., Ryan, Edward T., Meigs, James B., Florez, Jose C., Charles, Richelle C., Mercader, Josep M., and Leong, Aaron
- Subjects
- *
COVID-19 , *COVID-19 pandemic , *PREDICTION models , *PROTEOMICS , *BIOMARKERS - Abstract
Background: The high heterogeneity in the symptoms and severity of COVID-19 makes it challenging to identify high-risk patients early in the disease. Cardiometabolic comorbidities have shown strong associations with COVID-19 severity in epidemiologic studies. Cardiometabolic protein biomarkers, therefore, may provide predictive insight regarding which patients are most susceptible to severe illness from COVID-19. Methods: In plasma samples collected from 343 patients hospitalized with COVID-19 during the first wave of the pandemic, we measured 92 circulating protein biomarkers previously implicated in cardiometabolic disease. We performed proteomic analysis and developed predictive models for severe outcomes. We then used these models to predict the outcomes of out-of-sample patients hospitalized with COVID-19 later in the surge (N = 194). Results: We identified a set of seven protein biomarkers predictive of admission to the intensive care unit and/or death (ICU/death) within 28 days of presentation to care. Two of the biomarkers, ADAMTS13 and VEGFD, were associated with a lower risk of ICU/death. The remaining biomarkers, ACE2, IL-1RA, IL6, KIM1, and CTSL1, were associated with higher risk. When used to predict the outcomes of the future, out-of-sample patients, the predictive models built with these protein biomarkers outperformed all models built from standard clinical data, including known COVID-19 risk factors. Conclusions: These findings suggest that proteomic profiling can inform the early clinical impression of a patient's likelihood of developing severe COVID-19 outcomes and, ultimately, accelerate the recognition and treatment of high-risk patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad.
- Author
-
Bangs, Audrey C, Gastañaduy, Paul, Neilan, Anne M, Fiebelkorn, Amy Parker, Walker, Allison Taylor, Rao, Sowmya R, Ryan, Edward T, LaRocque, Regina C, Walensky, Rochelle P, and Hyle, Emily P
- Subjects
- *
MEASLES prevention , *AIR travel , *COMPARATIVE studies , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *COST effectiveness , *MMR vaccines , *SENSITIVITY & specificity (Statistics) , *TRAVEL hygiene , *CHILDREN - Abstract
Background Pediatric international travelers account for nearly half of measles importations in the United States. Over one third of pediatric international travelers depart the United States without the recommended measles-mumps-rubella (MMR) vaccinations: 2 doses for travelers ≥12 months and 1 dose for travelers 6 to <12 months. Methods We developed a model to compare 2 strategies among a simulated cohort of international travelers (6 months to <6 years): (1) No pretravel health encounter (PHE): travelers depart with baseline MMR vaccination status; (2) PHE: MMR-eligible travelers are offered vaccination. All pediatric travelers experience a destination-specific risk of measles exposure (mean, 30 exposures/million travelers). If exposed to measles, travelers' age and MMR vaccination status determine the risk of infection (range, 3%-90%). We included costs of medical care, contact tracing, and lost wages from the societal perspective. We varied inputs in sensitivity analyses. Model outcomes included projected measles cases, costs, and incremental cost-effectiveness ratios ($/quality-adjusted life year [QALY], cost-effectiveness threshold ≤$100 000/QALY). Results Compared with no PHE, PHE would avert 57 measles cases at $9.2 million/QALY among infant travelers and 7 measles cases at $15.0 million/QALY among preschool-aged travelers. Clinical benefits of PHE would be greatest for infants but cost-effective only for travelers to destinations with higher risk for measles exposure (ie, ≥160 exposures/million travelers) or if more US-acquired cases resulted from an infected traveler, such as in communities with limited MMR coverage. Conclusions Pretravel MMR vaccination provides the greatest clinical benefit for infant travelers and can be cost-effective before travel to destinations with high risk for measles exposure or from communities with low MMR vaccination coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
29. Impact of a human gut microbe on Vibrio cholerae host colonization through biofilm enhancement.
- Author
-
Barrasso, Kelsey, Chac, Denise, Debela, Meti D., Geigel, Catherine, Steenhaut, Anjali, Seda, Abigail Rivera, Dunmire, Chelsea N., Harris, Jason B., Larocque, Regina C., Midani, Firas S., Qadri, Firdausi, Jing Yan, Weil, Ana A., and Wai-Leung Ng
- Subjects
- *
VIBRIO cholerae , *BACTERIAL colonies , *BIOFILMS , *VIBRIO infections , *MICROORGANISMS , *HUMAN microbiota - Abstract
Recent studies indicate that the human intestinal microbiota could impact the outcome of infection by Vibrio cholerae, the etiological agent of the diarrheal disease cholera. A commensal bacterium, Paracoccus aminovorans, was previously identified in high abundance in stool collected from individuals infected with V. cholerae when compared to stool from uninfected persons. However, if and how P. aminovorans interacts with V. cholerae has not been experimentally determined; moreover, whether any association between this bacterium alters the behaviors of V. cholerae to affect the disease outcome is unclear. Here, we show that P. aminovorans and V. cholerae together form dual-species biofilm structure at the air-liquid interface, with previously uncharacterized novel features. Importantly, the presence of P. aminovorans within the murine small intestine enhances V. cholerae colonization in the same niche that is dependent on the Vibrio exopolysaccharide and other major components of mature V. cholerae biofilm. These studies illustrate that multispecies biofilm formation is a plausible mechanism used by a gut microbe to increase the virulence of the pathogen, and this interaction may alter outcomes in enteric infections. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. A Systems Biology Approach To Modeling Vibrio cholerae Gene Expression under Virulence-Inducing Conditions.
- Author
-
Kanjilal, Sanjat, Citorik, Robert, LaRocque, Regina C., Ramoni, Marco F., and Calderwood, Stephen B.
- Subjects
- *
VIBRIO cholerae , *GENE expression , *MICROBIAL virulence , *SYSTEMS biology , *GENES , *CHOLERA - Abstract
Vibrio cholerae is a Gram-negative bacillus that is the causative agent of cholera. Pathogenesis in vivo occurs through a series of spatiotemporally controlled events under the control of a gene cascade termed the ToxR regulon. Major genes in the ToxR regulon include the master regulators toxRS and tcpPH, the downstream regulator toxT, and virulence factors, the ctxAB and tcpA operons. Our current understanding of the dynamics of virulence gene expression is limited to microarray analyses of expression at selected time points. To better understand this process, we utilized a systems biology approach to examine the temporal regulation of gene expression in El Tor V. cholerae grown under virulence-inducing conditions in vitro (AKI medium), using high-resolution time series genomic profiling. Results showed that overall gene expression in AKI medium mimics that of in vivo studies but with less clear temporal separation between upstream regulators and downstream targets. Expression of toxRS was unaffected by growth under virulence-inducing conditions, but expression of toxT was activated shortly after switching from stationary to aerating conditions. The tcpA operon was also activated early during mid-exponential-phase growth, while the ctxAB operon was turned on later, after the rise in toxT expression. Expression of ctxAB continued to rise despite an eventual decrease in toxT. Cluster analysis of gene expression highlighted 15 hypothetical genes and six genes related to environmental information processing that represent potential new members of the ToxR regulon. This study applies systems biology tools to analysis of gene expression of V. cholerae in vitro and provides an important comparator for future studies done in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
31. Case 26-2010.
- Author
-
Pless, Misha L., Kroshinsky, Daniela, LaRocque, Regina C., Buchbinder, Bradley R., and Duncan, Lyn M.
- Subjects
- *
EYE diseases , *HODGKIN'S disease treatment , *THERAPEUTICS , *DRUG therapy , *OPTIC nerve diseases , *MONOCULAR vision - Abstract
The article describes the case of a 54-year-old man who presented with decreased central vision in his left eye and a rash. It says that prior to the man's admission to the hospital, he was diagnosed with stage IIB Hodgkin's lymphoma and he underwent treatment, which included chemotherapy, for 4 months. Five months before admission, the patient developed a macular rash on the trunk, associated with low-grade fevers. One doctor states the possibility of a disorder of the optic nerve or retina due to sudden monocular loss of central vision.
- Published
- 2010
- Full Text
- View/download PDF
32. An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh.
- Author
-
Uddin, Muhammad Ikhtear, Hossain, Motaher, Islam, Shahidul, Akter, Aklima, Nishat, Naoshin Sharmin, Nila, Tasnin Akter, Rafique, Tanzeem Ahmed, Leung, Daniel T., Calderwood, Stephen B., Ryan, Edward T., Harris, Jason B., LaRocque, Regina C., Bhuiyan, Taufiqur Rahman, and Qadri, Firdausi
- Subjects
- *
INTESTINAL infections , *MALNUTRITION , *ENZYME-linked immunosorbent assay , *INTESTINAL diseases , *PARASITIC diseases , *BIOMARKERS - Abstract
Interventional studies targeting environment enteropathy (EE) are impeded by the lack of appropriate, validated, non-invasive biomarkers of EE. Thus, we aimed to validate the association of potential biomarkers for EE with enteric infections and nutritional status in a longitudinal birth cohort study. We measured endotoxin core antibody (EndoCab) and soluble CD14 (sCD14) in serum, and myeloperoxidase (MPO) in feces using commercially available enzyme-linked immunosorbent assay (ELISA) kits. We found that levels of serum EndoCab and sCD14 increase with the cumulative incidence of enteric infections. We observed a significant correlation between the fecal MPO level in the children at 24 months of age with the total number of bacterial and viral infections, the total number of parasitic infections, and the total number of diarrheal episodes and diarrheal duration. We observed that the levels of serum EndoCab, sCD14, and fecal MPO at 3 months of age were significantly associated with whether children were malnourished at 18 months of age or not. Biomarkers such as fecal MPO, serum EndoCab and sCD14 in children at an early age may be useful as a measure of cumulative burden of preceding enteric infections, which are predictive of subsequent malnutrition status and may be useful non-invasive biomarkers for EE. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study.
- Author
-
Levade, Inès, Saber, Morteza M, Midani, Firas S, Chowdhury, Fahima, Khan, Ashraful I, Begum, Yasmin A, Ryan, Edward T, David, Lawrence A, Calderwood, Stephen B, Harris, Jason B, LaRocque, Regina C, Qadri, Firdausi, Shapiro, B Jesse, Weil, Ana A, and Midani, Firas
- Subjects
- *
VIBRIO infections , *CHOLERA , *VIBRIO cholerae , *METAGENOMICS , *SHOTGUN sequencing , *LONGITUDINAL method , *GENE families , *RESEARCH , *BIOLOGICAL evolution , *GRAM-negative bacteria , *RESEARCH methodology , *PROGNOSIS , *MEDICAL cooperation , *EVALUATION research , *SEVERITY of illness index , *COMPARATIVE studies , *GENOMES , *DISEASE susceptibility , *RESEARCH funding , *RECEIVER operating characteristic curves ,CHOLERA diagnosis - Abstract
Background: Susceptibility to Vibrio cholerae infection is affected by blood group, age, and preexisting immunity, but these factors only partially explain who becomes infected. A recent study used 16S ribosomal RNA amplicon sequencing to quantify the composition of the gut microbiome and identify predictive biomarkers of infection with limited taxonomic resolution.Methods: To achieve increased resolution of gut microbial factors associated with V. cholerae susceptibility and identify predictors of symptomatic disease, we applied deep shotgun metagenomic sequencing to a cohort of household contacts of patients with cholera.Results: Using machine learning, we resolved species, strains, gene families, and cellular pathways in the microbiome at the time of exposure to V. cholerae to identify markers that predict infection and symptoms. Use of metagenomic features improved the precision and accuracy of prediction relative to 16S sequencing. We also predicted disease severity, although with greater uncertainty than our infection prediction. Species within the genera Prevotella and Bifidobacterium predicted protection from infection, and genes involved in iron metabolism were also correlated with protection.Conclusion: Our results highlight the power of metagenomics to predict disease outcomes and suggest specific species and genes for experimental testing to investigate mechanisms of microbiome-related protection from cholera. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
34. Acquisition and Long-term Carriage of Multidrug-Resistant Organisms in US International Travelers.
- Author
-
Worby, Colin J, Earl, Ashlee M, Turbett, Sarah E, Becker, Margaret, Rao, Sowmya R, Oliver, Elizabeth, Walker, Allison Taylor, Walters, Maroya, Kelly, Paul, Leung, Daniel T, Knouse, Mark, Hagmann, Stefan H F, Ryan, Edward T, and LaRocque, Regina C
- Subjects
- *
TRAVEL hygiene , *TRAVELERS , *DRUG resistance in bacteria , *DIARRHEA - Abstract
We performed prospective screening of stool for multidrug-resistant organisms from 608 US international travelers and identified an acquisition rate of 38% following travel. Carriage rates remained significantly elevated for at least 6 months post-travel. Travel-related diarrhea was a risk factor for acquisition, as well as for long-term carriage upon return. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
35. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
- Author
-
Shirin, Tahmina, Bhuiyan, Taufiqur Rahman, Charles, Richelle C., Amin, Shaheena, Bhuiyan, Imran, Kawser, Zannat, Rahat, Asifuzaman, Alam, Ahmed Nawsher, Sultana, Sharmin, Aleem, Md Abdul, Khan, Manjur Hossain, Khan, Samsad Rabbani, LaRocque, Regina C., Calderwood, Stephen B., Ryan, Edward T., Slater, Damien M., Banu, Sayera, Clemens, John, Harris, Jason B., and Flora, Meerjady Sabrina
- Subjects
- *
COVID-19 , *ANTIBODY formation , *IMMUNOGLOBULIN A , *ENZYME-linked immunosorbent assay , *HERD immunity - Abstract
• Serum IgG developed in 95% mildly symptomatic patients by day 14 and all seroconverted by day 30. • Serum IgM and IgA antibody responses were lower and less frequent than corresponding IgG responses. • Serum IgM and IgA responses peaked and declined earlier in 100% of mild symptomatic individuals. • <45% of asymptomatic infected individuals had seroconverted by day 30 post-PCR diagnosis. • Impact on modeling of herd immunity. Studies on serological responses following coronavirus disease-2019 (COVID-19) have been published primarily in individuals who are moderately or severely symptomatic, but there are few data from individuals who are mildly symptomatic or asymptomatic. We measured IgG, IgM, and IgA to the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using enzyme-linked immunosorbent assay in mildly symptomatic (n = 108) and asymptomatic (n = 63) on days 1, 7, 14, and 30 following RT-PCR confirmation in Bangladesh and when compared with pre-pandemic samples, including healthy controls (n = 73) and individuals infected with other viruses (n = 79). Mildly symptomatic individuals developed IgM and IgA responses by day 14 in 72% and 83% of individuals, respectively, while 95% of individuals developed IgG response, and rose to 100% by day 30. In contrast, individuals infected with SARS-CoV-2 but who remained asymptomatic developed antibody responses significantly less frequently, with only 20% positive for IgA and 22% positive for IgM by day 14, and 45% positive for IgG by day 30 after infection. These results confirm immune responses are generated following COVID-19 who develop mildly symptomatic illness. However, those with asymptomatic infection do not respond or have lower antibody levels. These results will impact modeling needed for determining herd immunity generated by natural infection or vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
36. Prescribing Patterns of Antibiotics for the Self-Treatment of Travelers' Diarrhea in Global TravEpiNet, 2009–2018.
- Author
-
Gandhi, Aditya R, Rao, Sowmya R, Chen, Lin H, Nelson, Michael D, Ryan, Edward T, LaRocque, Regina C, and Hyle, Emily P
- Subjects
- *
ANTIBIOTICS , *AZITHROMYCIN , *DIARRHEA , *TIME series analysis , *TRAVELERS - Abstract
Background International travelers are often prescribed antibiotics for self-treatment of travelers' diarrhea (TD), but the benefits and risks of antibiotics are debated. We assessed the prescribing patterns of empiric antibiotics for TD in international travelers evaluated at Global TravEpiNet (GTEN) sites (2009–2018). Methods We performed a prospective, multisite cross-sectional study regarding antibiotic prescriptions for the self-treatment of TD at 31 GTEN sites providing pretravel consultations to adult international travelers. We described traveler demographics, itineraries, and antibiotic(s) prescribed. We used multivariable logistic regressions to assess the association of year of consultation with antibiotic prescribing (yes/no) and class (fluoroquinolones vs azithromycin). We performed interrupted time-series analyses to examine differences in prescribing before and after the Food and Drug Administration (FDA) warning on fluoroquinolones (July 2016). Results Antibiotics were not prescribed in 23 096 (22.2%) of 103 843 eligible pretravel GTEN consultations; azithromycin and fluoroquinolones were most frequently prescribed. Antibiotic prescribing declined significantly each year between 2009 and 2018 (odds ratio [OR], 0.84; 95% CI, 0.79–0.89), as did fluoroquinolone prescribing, relative to azithromycin (OR, 0.77; 95% CI, 0.73–0.82). The rate of decline in fluoroquinolone prescribing was significantly greater after the FDA fluoroquinolone warning (15.3%/year) than before (1.1%/year; P <.001). Conclusions Empiric antibiotics for TD were prescribed in >75% of pretravel GTEN consultations, but antibiotic prescribing declined steadily between 2009 and 2018. Fluoroquinolones were less frequently prescribed than azithromycin, especially after the 2016 FDA fluoroquinolone warning. Emphasis on the risks of antibiotics may influence antibiotic prescribing by providers for empiric treatment of TD. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.
- Author
-
Hyle, Emily P, Fields, Naomi F, Fiebelkorn, Amy Parker, Walker, Allison Taylor, Gastañaduy, Paul, Rao, Sowmya R, Ryan, Edward T, LaRocque, Regina C, and Walensky, Rochelle P
- Subjects
- *
PREVENTION of communicable diseases , *MEASLES prevention , *MMR vaccines , *MEDICAL care costs , *VACCINATION , *COST effectiveness , *DECISION trees , *ECONOMIC aspects of diseases , *EPIDEMICS , *MEASLES , *RISK assessment , *TRAVEL hygiene , *VACCINES , *DISEASE risk factors - Abstract
Background Measles importations and the subsequent spread from US travelers returning from abroad are responsible for most measles cases in the United States. Increasing measles-mumps-rubella (MMR) vaccination among departing US travelers could reduce the clinical impact and costs of measles in the United States. Methods We designed a decision tree to evaluate MMR vaccination at a pretravel health encounter (PHE), compared with no encounter. We derived input parameters from Global TravEpiNet data and literature. We quantified Riskexposure to measles while traveling and the average number of US-acquired cases and contacts due to a measles importation. In sensitivity analyses, we examined the impact of destination-specific Riskexposure, including hot spots with active measles outbreaks; the percentage of previously-unvaccinated travelers; and the percentage of travelers returning to US communities with heterogeneous MMR coverage. Results The no-encounter strategy projected 22 imported and 66 US-acquired measles cases, costing $14.8M per 10M travelers. The PHE strategy projected 15 imported and 35 US-acquired cases at $190.3M per 10M travelers. PHE was not cost effective for all international travelers (incremental cost-effectiveness ratio [ICER] $4.6M/measles case averted), but offered better value (ICER <$100 000/measles case averted) or was even cost saving for travelers to hot spots, especially if travelers were previously unvaccinated or returning to US communities with heterogeneous MMR coverage. Conclusions PHEs that improve MMR vaccination among US international travelers could reduce measles cases, but are costly. The best value is for travelers with a high likelihood of measles exposure, especially if the travelers are previously unvaccinated or will return to US communities with heterogeneous MMR coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
38. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection.
- Author
-
Midani, Firas S, Weil, Ana A, Chowdhury, Fahima, Begum, Yasmin A, Khan, Ashraful I, Debela, Meti D, Durand, Heather K, Reese, Aspen T, Nimmagadda, Sai N, Silverman, Justin D, Ellis, Crystal N, Ryan, Edward T, Calderwood, Stephen B, Harris, Jason B, Qadri, Firdausi, David, Lawrence A, and LaRocque, Regina C
- Subjects
- *
PATHOGENIC microorganisms , *COMMUNICABLE diseases , *VIBRIO cholerae , *INFECTION , *MEDICAL microbiology , *MICROBIOLOGY - Abstract
Background: Cholera is a public health problem worldwide, and the risk factors for infection are only partially understood.Methods: We prospectively studied household contacts of patients with cholera to compare those who were infected to those who were not. We constructed predictive machine learning models of susceptibility, using baseline gut microbiota data. We identified bacterial taxa associated with susceptibility to Vibrio cholerae infection and tested these taxa for interactions with V. cholerae in vitro.Results: We found that machine learning models based on gut microbiota, as well as models based on known clinical and epidemiological risk factors, predicted V. cholerae infection. A predictive gut microbiota of roughly 100 bacterial taxa discriminated between contacts who developed infection and those who did not. Susceptibility to cholera was associated with depleted levels of microbes from the phylum Bacteroidetes. By contrast, a microbe associated with cholera by our modeling framework, Paracoccus aminovorans, promoted the in vitro growth of V. cholerae. Gut microbiota structure, clinical outcome, and age were also linked.Conclusion: These findings support the hypothesis that abnormal gut microbial communities are a host factor related to V. cholerae susceptibility. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
39. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
- Author
-
Aktar, Amena, Rahman, M. Arifur, Afrin, Sadia, Akter, Aklima, Uddin, Taher, Yasmin, Tahirah, Sami, Md. Israk Nur, Dash, Pinki, Jahan, Sultana Rownok, Chowdhury, Fahima, Khan, Ashraful I., LaRocque, Regina C., Charles, Richelle C., Bhuiyan, Taufiqur Rahman, Mandlik, Anjali, Kelly, Meagan, Kováč, Pavol, Xu, Peng, Calderwood, Stephen B., and Harris, Jason B.
- Subjects
- *
VIBRIO cholerae , *CHOLERA , *POLYSACCHARIDES , *B cells , *IMMUNOGLOBULIN A , *IMMUNOGLOBULIN G , *PATIENTS - Abstract
Background: The mediators of protection against cholera, a severe dehydrating illness of humans caused by Vibrio cholerae, are unknown. We have previously shown that plasma IgA as well as memory B IgG cells targeting lipopolysaccharide (LPS) of Vibrio cholerae O1 correlate with protection against V. cholerae O1 infection among household contacts of cholera patients. Protection against cholera is serogroup specific, and serogroup specificity is defined by the O-specific polysaccharide (OSP) component of LPS. Therefore, we prospectively followed household contacts of cholera patients to determine whether OSP-specific immune responses present at the time of enrollment are associated with protection against V. cholerae infection. Methodology: In this study, we enrolled two hundred forty two household contacts of one hundred fifty index patients who were infected with Vibrio cholerae. We determined OSP-specific memory B cells and plasma IgA, IgG and IgM antibody responses on study entry (day 2). Principle findings: The presence of OSP-specific plasma IgA, IgM, and IgG antibody responses on study entry were associated with a decrease in the risk of infection in household contacts (IgA, p = 0.015; IgM, p = 0.01, and IgG, p = 0.024). In addition, the presence of OSP-specific IgG memory B cell responses in peripheral blood on study entry was also associated with a decreased risk of infection (44% reduction; 95% CI: 31.1 to 99.8) in contacts. No protection was associated with cholera toxin B subunit (CtxB)-specific memory B cell responses. Conclusion: These results suggest that immune responses that target OSP, both in plasma and memory responses, may be important in mediating protection against infection with V. cholerae O1. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
40. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
- Author
-
Islam, Kamrul, Hossain, Motaher, Kelly, Meagan, Mayo Smith, Leslie M., Charles, Richelle C., Bhuiyan, Taufiqur Rahman, Kováč, Pavol, Xu, Peng, LaRocque, Regina C., Calderwood, Stephen B., Simon, Jakub K., Chen, Wilbur H., Haney, Douglas, Lock, Michael, Lyon, Caroline E., Kirkpatrick, Beth D., Cohen, Mitchell, Levine, Myron M., Gurwith, Marc, and Harris, Jason B.
- Subjects
- *
CHOLERA , *IMMUNE response , *IMMUNIZATION , *B cells , *CLINICAL trials - Abstract
Background: Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correlate with protection against cholera. Methodology: We assessed adult North American volunteers (n = 46) who were vaccinated with 5 × 108 colony-forming units (CFU) of oral cholera vaccine CVD 103-HgR and then orally challenged with approximately 1 × 105 CFU of wild-type V. cholerae O1 El Tor Inaba strain N16961, either 10 or 90 days post-vaccination. Principal findings: Vaccination was associated with induction of significant serum IgM and IgA anti-OSP and vibriocidal antibody responses within 10 days of vaccination. There was significant correlation between anti-OSP and vibriocidal antibody responses. IgM and IgA anti-OSP responses on day 10 following vaccination were associated with lower post-challenge stool volume (r = −0.44, P = 0.002; r = −0.36, P = 0.01; respectively), and none of 27 vaccinees who developed a ≥1.5 fold increase in any antibody isotype targeting OSP on day 10 following vaccination compared to baseline developed moderate or severe cholera following experimental challenge, while 5 of 19 who did not develop such anti-OSP responses did (P = 0.01). Conclusion: Oral vaccination with live attenuated cholera vaccine CVD 103-HgR induces antibodies that target V. cholerae OSP, and these anti-OSP responses correlate with protection against diarrhea following experimental challenge with V. cholerae O1. Trial registration: ClinicalTrials.gov [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
41. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.
- Author
-
Hyle, Emily P., Rao, Sowmya R., Jentes, Emily S., Fiebelkorn, Amy Parker, Hagmann, Stefan H. F., Walker, Allison Taylor, Walensky, Rochelle P., Ryan, Edward T., and LaRocque, Regina C.
- Subjects
- *
VACCINATION , *MEASLES vaccines , *RUBELLA vaccines , *MUMPS vaccines , *PUBLIC health , *DECISION making in clinical medicine - Abstract
Background: Measles outbreaks continue to occur in the United States and are mostly due to infections in returning travelers. Objective: To describe how providers assessed the measles immunity status of departing U.S. adult travelers seeking pretravel consultation and to assess reasons given for nonvaccination among those considered eligible to receive the measles, mumps, rubella (MMR) vaccine. Design: Observational study in U.S. pretravel clinics. Setting: 24 sites associated with Global TravEpiNet (GTEN), a Centers for Disease Control and Prevention–funded consortium. Patients: Adults (born in or after 1957) attending pretravel consultations at GTEN sites (2009 to 2014). Measurements: Structured questionnaire completed by traveler and provider during pretravel consultation. Results: 40 810 adult travelers were included; providers considered 6612 (16%) to be eligible for MMR vaccine at the time of pretravel consultation. Of the MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%) were not vaccinated because of traveler refusal, 966 (28%) because of provider decision, and 822 (24%) because of health systems barriers. Most MMR-eligible travelers who were not vaccinated were evaluated in the South (2262 travelers [65%]) or at nonacademic centers (1777 travelers [51%]). Nonvaccination due to traveler refusal was most frequent in the South (1432 travelers [63%]) and in nonacademic centers (1178 travelers [66%]). Limitation: These estimates could underrepresent the opportunities for MMR vaccination because providers accepted verbal histories of disease and vaccination as evidence of immunity. Conclusion: Of U.S. adult travelers who presented for pretravel consultation at GTEN sites, 16% met criteria for MMR vaccination according to the provider's assessment, but fewer than half of these travelers were vaccinated. An increase in MMR vaccination of eligible U.S. adult travelers could reduce the likelihood of importation and transmission of measles virus. Primary Funding Source: Centers for Disease Control and Prevention, National Institutes of Health, and the Steve and Deborah Gorlin MGH Research Scholars Award. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
42. Measuring Success in Global Health Training: Data From 14 Years of a Postdoctoral Fellowship in Infectious Diseases and Tropical Medicine.
- Author
-
Tucker, Joseph D., Hughes, Molly A., Durvasula, Ravi V., Vinetz, Joseph M., McGovern, Victoria P., Schultz, Rhonda, Dunavan, Claire Panosian, Wilson, Mary E., Milner, Danny A., LaRocque, Regina C., Calderwood, Stephen B., Guerrant, Richard L., Weller, Peter F., and Taylor, Terrie E.
- Subjects
- *
MEDICAL education , *POSTDOCTORAL programs , *GLOBALIZATION , *TROPICAL medicine , *RATE of return - Abstract
Background. In modern academic medicine, especially in the fields of infectious diseases and global health, aspiring physician- scientists often wait years before achieving independence as basic, translational, and clinical investigators. This study employed mixed methods to evaluate the success of the Burroughs Wellcome Fund/American Society for Tropical Medicine and Hygiene (BWF/ASTMH) global health postdoctoral fellowship in promoting scientific independence. Methods. We examined quantitative data obtained from the National Institutes of Health (NIH) and qualitative data provided by the ASTMH and program participants to assess BWF/ASTMH trainees’ success in earning NIH grants, publishing manuscripts, and gaining faculty positions. We also calculated the return on investment (ROI) associated with the training program by dividing direct costs of NIH research grants awarded to trainees by the direct costs invested by the BWF/ASTMH fellowship. Results. Forty-one trainees received fellowships between 2001 and 2015. Within 3 years of completing their fellowships, 21 of 35 (60%) had received career development awards, and within 5 years, 12 of 26 (46%) had received independent research awards. Overall, 22 of 35 (63%) received 1 or more research awards. BWF/ASTMH recipients with at least 3 years of follow-up data had coauthored a mean of 36 publications (range, 2–151) and 29 of 35 (82%) held academic positions. The return on investment was 11.9 overall and 31.8 for fellowships awarded between 2001 and 2004. Conclusions. Between 2001 and 2015, the BWF/ASTMH postdoctoral training program successfully facilitated progress to scientific independence. This program model underscores the importance of custom-designed postdoctoral training as a bridge to NIH awards and professional autonomy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
43. Characteristics of US Travelers to Zika Virus-Affected Countries in the Americas, March 2015-October 2016.
- Author
-
Lammert, Sara, Walker, Allison Taylor, Erskine, Stefanie, Rao, Sowmya R., Esposito, Douglas H., Ryan, Edward T., Robbins, Gregory K., and LaRocque, Regina C.
- Subjects
- *
ZIKA virus , *ZIKA Virus Epidemic, 2015-2016 , *ZIKA virus infections , *MATERNAL health , *TRAVELERS , *DISEASE risk factors , *VIRAL transmission , *COMMUNICABLE disease epidemiology , *COMPARATIVE studies , *HISTORY , *RESEARCH methodology , *MEDICAL cooperation , *PREGNANCY complications , *RESEARCH , *RESEARCH funding , *SEASONS , *TRAVEL , *EVALUATION research - Abstract
Zika virus has recently been introduced to the Americas and is spreading rapidly. We evaluated the characteristics of US travelers to Zika virus-affected countries who were seen at Global TravEpiNet sites during March 2015-October 2016. Nearly three quarters of travelers were men or women of reproductive age. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
44. Pre-Travel Medical Preparation of Business and Occupational Travelers.
- Author
-
Khan, Nomana M., Jentes, Emily S., Brown, Clive, Han, Pauline, Rao, Sowmya R., Kozarsky, Phyllis, Hagmann, Stefan H. F., LaRocque, Regina C., and Ryan, Edward T.
- Subjects
- *
BUSINESS , *EMPLOYEE attitudes , *HEPATITIS B vaccines , *INDUSTRIAL hygiene , *INFLUENZA vaccines , *TRAVEL hygiene , *MENINGOCOCCAL vaccines - Abstract
Objectives: The aim of the study was to understand more about pre-travel preparations and itineraries of business and occupational travelers. Methods: De-identified data from 18 Global TravEpiNet clinics from January 2009 to December 2012 were analyzed. Results: Of 23,534 travelers, 61% were non-occupational and 39% occupational. Business travelers were more likely to be men, had short times to departure and shorter trip durations, and commonly refused influenza, meningococcal, and hepatitis B vaccines. Most business travelers indicated that employers suggested the pre-travel health consultation, whereas non-occupational travelers sought consultations because of travel health concerns. Conclusions: Sub-groups of occupational travelers have characteristic profiles, with business travelers being particularly distinct. Employers play a role in encouraging business travelers to seek pre-travel consultations. Such consultations, even if scheduled immediately before travel, can identify vaccination gaps and increase coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
45. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014.
- Author
-
Chowdhury, Fahima, Mather, Alison E., Begum, Yasmin Ara, Asaduzzaman, Muhammad, Baby, Nabilah, Sharmin, Salma, Biswas, Rajib, Ikhtear Uddin, Muhammad, LaRocque, Regina C., Harris, Jason B., Calderwood, Stephen B., Ryan, Edward T., Clemens, John D., Thomson, Nicholas R., and Qadri, Firdausi
- Subjects
- *
CHOLERA , *VIBRIO infections , *MEDICAL care , *PANDEMICS - Abstract
Background: Cholera is endemic in Bangladesh, with outbreaks reported annually. Currently, the majority of epidemic cholera reported globally is El Tor biotype Vibrio cholerae isolates of the serogroup O1. However, in Bangladesh, outbreaks attributed to V. cholerae serogroup O139 isolates, which fall within the same phylogenetic lineage as the O1 serogroup isolates, were seen between 1992 and 1993 and in 2002 to 2005. Since then, V. cholerae serogroup O139 has only been sporadically isolated in Bangladesh and is now rarely isolated elsewhere. Methods: Here, we present case histories of four cholera patients infected with V. cholerae serogroup O139 in 2013 and 2014 in Bangladesh. We comprehensively typed these isolates using conventional approaches, as well as by whole genome sequencing. Phenotypic typing and PCR confirmed all four isolates belonging to the O139 serogroup. Findings: Whole genome sequencing revealed that three of the isolates were phylogenetically closely related to previously sequenced El Tor biotype, pandemic 7, toxigenic V. cholerae O139 isolates originating from Bangladesh and elsewhere. The fourth isolate was a non-toxigenic V. cholerae that, by conventional approaches, typed as O139 serogroup but was genetically divergent from previously sequenced pandemic 7 V. cholerae lineages belonging to the O139 or O1 serogroups. Conclusion: These results suggest that previously observed lineages of V. cholerae O139 persist in Bangladesh and can cause clinical disease and that a novel disease-causing non-toxigenic O139 isolate also occurs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
46. Cholera in pregnancy: Clinical and immunological aspects.
- Author
-
Khan, Ashraful I., Chowdhury, Fahima, Leung, Daniel T., Larocque, Regina C., Harris, Jason B., Ryan, Edward T., Calderwood, Stephen B., and Qadri, Firdausi
- Subjects
- *
CHOLERA , *PREGNANCY complications , *ENDOTOXINS , *IMMUNE response , *PATIENTS ,CHOLERA diagnosis - Abstract
Summary Background The objective of this study was to examine the clinical and immunological features of cholera in pregnancy. Methods Women of reproductive age presenting to the icddr,b Dhaka hospital with cholera, and enrolled as part of a larger cohort study, were tested for pregnancy on admission. We compared initial clinical features and immune responses of pregnant patients with non-pregnant female patients at days 2, 7 and 21 after infection. Results Among reproductive age women enrolled between January 2001 and May 2006, 9.7% (14/144) were pregnant. The duration of diarrhoea prior to admission tended to be higher in pregnant compared to non-pregnant patients (p=0.08), but other clinical characteristics did not differ. Antibody responses to cholera toxin B subunit (CtxB), toxin-coregulated pilus A (TcpA), Vibrio cholerae lipopolysaccharide (LPS), and serum vibriocidal antibody responses, were comparable between pregnant and non-pregnant patients. There were no deaths among the pregnant cases or non-pregnant controls, and no adverse foetal outcomes, including stillbirths, during 21 days of follow up of pregnant cases. Conclusions To our knowledge, this is the first report of immune responses in pregnant women with cholera. We found that pregnant woman early in pregnancy has comparable clinical illness and subsequent immune responses compared to non-pregnant women. These findings suggest that the evaluation of safety and immunogenicity of oral cholera vaccines in pregnancy should be an area of future investigations. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
47. Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection.
- Author
-
Ivers, Louise C., Charles, Richelle C., Hilaire, Isabelle J., Mayo-Smith, Leslie M., Teng, Jessica E., Jerome, J. Gregory, Rychert, Jenna, LaRocque, Regina C., Peng Xu, Kováč, Pavol, Ryan, Edward T., Qadri, Firdausi, Almazor, Charles P., Franke, Molly F., and Harris, Jason B.
- Subjects
- *
CHOLERA vaccines , *HIV infections , *VIRAL vaccines , *SEROCONVERSION ,DISEASES in adults - Abstract
We evaluated immune responses following bivalent oral cholera vaccination (Shanchol [Shantha Biotechnics]; BivWC) in a cohort of 25 human immunodeficiency virus (HIV)-infected adults in Haiti. Compared with adults without HIV infection, vaccination in HIV-infected individuals resulted in lower vibriocidal responses against Vibrio cholerae O1, and there was a positive relationship between the CD4+ T-cell count and vibriocidal responses following vaccination. Nevertheless, seroconversion occurred at a rate of 65% against the Ogawa serotype and 74% against the Inaba serotype in adults with HIV infection. These results suggest that the vaccine retains substantial immunogenicity in adults with HIV infection and may benefit this population by protecting against cholera. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
48. Implementing expanded COVID-19 testing in Massachusetts community health centers through community partnerships: Protocol for an interrupted time series and stepped wedge study design.
- Author
-
Kruse, Gina R., Pelton-Cairns, Leslie, Taveras, Elsie M., Dargon-Hart, Susan, Gundersen, Daniel A., Lee, Rebekka M., Bierer, Barbara E., Lawlor, Erica, LaRocque, Regina C., Marcus, Julia L., Davies, Madeline E., and Emmons, Karen M.
- Subjects
- *
COVID-19 testing , *COMMUNITY centers , *TIME series analysis , *MEDICAL centers , *PUBLIC health , *COMMUNITIES - Abstract
Community Health Centers (CHCs) are a critical source of care for low-income and non-privately insured populations. During the pandemic, CHCs have leveraged their infrastructure and role as a trusted source of care to engage the communities they serve in COVID-19 testing. To directly address the impact that COVID-19 has had on historically marginalized populations in Massachusetts, we designed a study of community-engaged COVID-19 testing expansion: (1) leveraging existing partnerships to accelerate COVID-19 testing and rapidly disseminate effective implementation strategies; (2) incorporating efforts to address key barriers to testing participation in communities at increased risk for COVID-19; (3) further developing partnerships between communities and CHCs to address testing access and disparities; (4) grounding the study in the development of a shared ethical framework for advancing equity in situations of scarcity; and (5) developing mechanisms for communication and science translation to support community outreach. We use a controlled interrupted time series design, comparing number of COVID-19 tests overall and among people identified as members of high-risk groups served by intervention CHCs compared with six matched control CHCs in Massachusetts, followed by a stepped wedge design to pilot test strategies for tailored outreach by CHCs. Here, we describe a community-partnered strategy to accelerate COVID-19 testing in historically marginalized populations that provides ongoing resources to CHCs for addressing testing needs in their communities. The study aligns with principles of community-engaged research including shared leadership, adequate resources for community partners, and the flexibility to respond to changing needs over time. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
- Author
-
Sayeed, Md. Abu, Bufano, Meagan Kelly, Xu, Peng, Eckhoff, Grace, Charles, Richelle C., Alam, Mohammad Murshid, Sultana, Tania, Rashu, Md. Rasheduzzaman, Berger, Amanda, Gonzalez-Escobedo, Geoffrey, Mandlik, Anjali, Bhuiyan, Taufiqur Rahman, Leung, Daniel T., LaRocque, Regina C., Harris, Jason B., Calderwood, Stephen B., Qadri, Firdausi, Vann, W. F., Kováč, Pavol, and Ryan, Edward T.
- Subjects
- *
VIBRIO cholerae , *CHOLERA , *POLYSACCHARIDES , *LIPOPOLYSACCHARIDES , *IMMUNIZATION , *IMMUNE response , *VACCINATION - Abstract
Background: Vibrio cholerae is the cause of cholera, a severe watery diarrhea. Protection against cholera is serogroup specific. Serogroup specificity is defined by the O-specific polysaccharide (OSP) component of lipopolysaccharide (LPS). Methodology: Here we describe a conjugate vaccine for cholera prepared via squaric acid chemistry from the OSP of V. cholerae O1 Inaba strain PIC018 and a recombinant heavy chain fragment of tetanus toxin (OSP:rTTHc). We assessed a range of vaccine doses based on the OSP content of the vaccine (10-50 μg), vaccine compositions varying by molar loading ratio of OSP to rTTHc (3:1, 5:1, 10:1), effect of an adjuvant, and route of immunization. Principle Findings: Immunized mice developed prominent anti-OSP and anti-TT serum IgG responses, as well as vibriocidal antibody and memory B cell responses following intramuscular or intradermal vaccination. Mice did not develop anti-squarate responses. Intestinal lamina proprial IgA responses targeting OSP occurred following intradermal vaccination. In general, we found comparable immune responses in mice immunized with these variations, although memory B cell and vibriocidal responses were blunted in mice receiving the highest dose of vaccine (50 μg). We found no appreciable change in immune responses when the conjugate vaccine was administered in the presence or absence of immunoadjuvant alum. Administration of OSP:rTTHc resulted in 55% protective efficacy in a mouse survival cholera challenge model. Conclusion: We report development of an Inaba OSP:rTTHc conjugate vaccine that induces memory responses and protection against cholera in mice. Development of an effective cholera conjugate vaccine that induces high level and long-term immune responses against OSP would be beneficial, especially in young children who respond poorly to polysaccharide antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
50. Household Transmission of Vibrio cholerae in Bangladesh.
- Author
-
Sugimoto, Jonathan D., Koepke, Amanda A., Kenah, Eben E., Halloran, M. Elizabeth, Chowdhury, Fahima, Khan, Ashraful I., LaRocque, Regina C., Yang, Yang, Ryan, Edward T., Qadri, Firdausi, Calderwood, Stephen B., Harris, Jason B., and Longini Jr., Ira M.
- Subjects
- *
CHOLERA , *VIBRIO cholerae , *WATERBORNE infection , *VIBRIO infections , *FECAL contamination , *FOOD contamination - Abstract
Background: Vibrio cholerae infections cluster in households. This study's objective was to quantify the relative contribution of direct, within-household exposure (for example, via contamination of household food, water, or surfaces) to endemic cholera transmission. Quantifying the relative contribution of direct exposure is important for planning effective prevention and control measures. Methodology/Principal Findings: Symptom histories and multiple blood and fecal specimens were prospectively collected from household members of hospital-ascertained cholera cases in Bangladesh from 2001–2006. We estimated the probabilities of cholera transmission through 1) direct exposure within the household and 2) contact with community-based sources of infection. The natural history of cholera infection and covariate effects on transmission were considered. Significant direct transmission (p-value<0.0001) occurred among 1414 members of 364 households. Fecal shedding of O1 El Tor Ogawa was associated with a 4.9% (95% confidence interval: 0.9%–22.8%) risk of infection among household contacts through direct exposure during an 11-day infectious period (mean length). The estimated 11-day risk of O1 El Tor Ogawa infection through exposure to community-based sources was 2.5% (0.8%–8.0%). The corresponding estimated risks for O1 El Tor Inaba and O139 infection were 3.7% (0.7%–16.6%) and 8.2% (2.1%–27.1%) through direct exposure, and 3.4% (1.7%–6.7%) and 2.0% (0.5%–7.3%) through community-based exposure. Children under 5 years-old were at elevated risk of infection. Limitations of the study may have led to an underestimation of the true risk of cholera infection. For instance, available covariate data may have incompletely characterized levels of pre-existing immunity to cholera infection. Transmission via direct exposure occurring outside of the household was not considered. Conclusions: Direct exposure contributes substantially to endemic transmission of symptomatic cholera in an urban setting. We provide the first estimate of the transmissibility of endemic cholera within prospectively-followed members of households. The role of direct transmission must be considered when planning cholera control activities. Author Summary: Since John Snow's ground-breaking investigations of the devastating outbreaks in 19th-century London, cholera has been considered the quintessential waterborne human infection, transmitting via fecal contamination of environmental water sources. Recently, renewed interest has been paid to the potential importance of transmission through direct exposure within close-contact groups, such as, via fecal contamination of surfaces, food, or drinking water within households. Significant direct transmission of cholera within close contact groups would represent a new target for innovative prevention and control strategies. We estimated the probability of transmission 1) via direct contact within 364 urban households located in an endemic cholera setting (Dhaka, Bangladesh) and 2) via exposure to sources located outside of these households. In this setting we estimated a 4 to 8 percent probability of becoming infected with cholera via direct exposure within households in this setting versus a 2 to 3 percent likelihood of infection due to exposure to external sources over a comparable time period. Our results demonstrate that direct (within-household) transmission is a significant component of endemic cholera transmission, suggesting that biomedical and behavioral-modification interventions specifically targeting this mode of transmission could substantially reduce the cholera burden in this type of setting. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.